The global inactivated vaccines market has witnessed consistent growth in recent years due to rising awareness about infectious diseases, increasing immunization programs, and growing investment in vaccine research. The market was valued at US$ 40.6 Bn in 2023 and is projected to reach US$ 74.8 Bn by the end of 2034, expanding at a compound annual growth rate (CAGR) of 5.7% between 2024 and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek